Literature DB >> 32222455

Effect of prostaglandin analogs: Latanoprost, bimatoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human trabecular meshwork endothelial cells.

Jae Young Heo1, Yen Hoong Ooi2, Douglas J Rhee3.   

Abstract

Bimatoprost, latanoprost, and unoprostone are prostaglandin F2α analogs (PGAs) and are used to lower intraocular pressure. We investigated the free acid effects of these three prostaglandin analogs: bimatoprost, latanoprost, and unoprostone on human matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMP) in the trabecular meshwork (TM) cells. Immunoblot results show that all three PGAs generally increased MMPs-1,9 and TIMPs-4. Additionally, bimatoprost and latanoprost both increased MMP-3 and TIMP-2, while unoprostone had an indeterminate effect on both. Zymography results show that all three PGAs except unoprostone increased intermediate MMP-1 activity while bimatoprost and latanoprost increased MMP-9 activity. Together, these data suggest that the balance between MMPs and TIMPs correlate to the relative intraocular pressure lowering effectiveness observed in clinical studies of these PGAs.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Glaucoma; Matrix metalloproteinases; Open-angle glaucoma; Prostaglandin analogs; Tissue inhibitors of metalloproteinases; Trabecular meshwork endothelial cells; Transcriptional expression

Mesh:

Substances:

Year:  2020        PMID: 32222455      PMCID: PMC7262744          DOI: 10.1016/j.exer.2020.108019

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  52 in total

Review 1.  Matrix metalloproteinases.

Authors:  H Nagase; J F Woessner
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

2.  A randomized, investigator-masked comparison of diurnal responder rates with bimatoprost and latanoprost in the lowering of intraocular pressure.

Authors:  Neil Choplin; Paula Bernstein; Amy L Batoosingh; Scott M Whitcup
Journal:  Surv Ophthalmol       Date:  2004-03       Impact factor: 6.048

3.  Mechanism of basement membrane dissolution preceding corneal ulceration.

Authors:  M Matsubara; J D Zieske; M E Fini
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-12       Impact factor: 4.799

4.  The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study.

Authors:  G S Butler; M J Butler; S J Atkinson; H Will; T Tamura; S Schade van Westrum; T Crabbe; J Clements; M P d'Ortho; G Murphy
Journal:  J Biol Chem       Date:  1998-01-09       Impact factor: 5.157

5.  Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost.

Authors:  Dong-Jin Oh; Jonathan L Martin; Adrienne J Williams; Rachel E Peck; Corinna Pokorny; Paul Russell; David E Birk; Douglas J Rhee
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-03       Impact factor: 4.799

Review 6.  Bimatoprost versus latanoprost in lowering intraocular pressure in glaucoma and ocular hypertension: results from parallel-group comparison trials.

Authors:  Steven T Simmons; Monte S Dirks; Robert J Noecker
Journal:  Adv Ther       Date:  2004 Jul-Aug       Impact factor: 3.845

7.  Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.

Authors:  N A Sharif; C R Kelly; J Y Crider; G W Williams; S X Xu
Journal:  J Ocul Pharmacol Ther       Date:  2003-12       Impact factor: 2.671

8.  Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics.

Authors:  R F Brubaker; E O Schoff; C B Nau; S P Carpenter; K Chen; A M Vandenburgh
Journal:  Am J Ophthalmol       Date:  2001-01       Impact factor: 5.258

Review 9.  Role of matrix metalloproteinases and their inhibitors in tumor invasion and metastasis.

Authors:  P Z Khasigov; O V Podobed; T S Gracheva; K D Salbiev; S V Grachev; T T Berezov
Journal:  Biochemistry (Mosc)       Date:  2003-07       Impact factor: 2.487

10.  Effect of matrix metalloproteinases activity on outflow in perfused human organ culture.

Authors:  J M Bradley; J Vranka; C M Colvis; D M Conger; J P Alexander; A S Fisk; J R Samples; T S Acott
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-12       Impact factor: 4.799

View more
  4 in total

Review 1.  The Role of Metalloproteinases and Their Tissue Inhibitors on Ocular Diseases: Focusing on Potential Mechanisms.

Authors:  Miłosz Caban; Katarzyna Owczarek; Urszula Lewandowska
Journal:  Int J Mol Sci       Date:  2022-04-12       Impact factor: 6.208

2.  The Dual Effect of Rho-Kinase Inhibition on Trabecular Meshwork Cells Cytoskeleton and Extracellular Matrix in an In Vitro Model of Glaucoma.

Authors:  Juliette Buffault; Françoise Brignole-Baudouin; Élodie Reboussin; Karima Kessal; Antoine Labbé; Stéphane Mélik Parsadaniantz; Christophe Baudouin
Journal:  J Clin Med       Date:  2022-02-15       Impact factor: 4.241

Review 3.  Replacement in angiogenesis research: Studying mechanisms of blood vessel development by animal-free in vitro, in vivo and in silico approaches.

Authors:  Matthias W Laschke; Yuan Gu; Michael D Menger
Journal:  Front Physiol       Date:  2022-08-17       Impact factor: 4.755

Review 4.  Analysis of the Responsiveness of Latanoprost, Travoprost, Bimatoprost, and Tafluprost in the Treatment of OAG/OHT Patients.

Authors:  Ziyan Cai; Mengdan Cao; Ke Liu; Xuanchu Duan
Journal:  J Ophthalmol       Date:  2021-05-25       Impact factor: 1.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.